HIGHLIGHTS
- who: January and collaborators from the Shanghai Changzheng Hospital, China Columbia, United States have published the Article: Cell death-related biomarker SLC2A1 has a signi fi cant role in prognosis prediction and immunotherapy ef cacy evaluation in pan-cancer, in the Journal: (JOURNAL)
- what: The study provides a comprehensive and systematic analysis of the role of SLC2A1 in human cancers, investigates its differences and commonalities among different cancer species, and explores its potential as a pancancer biomarker.
- how: In GEPIA2 the matched TCGA normal and genotype-tissue expression dataset (GTEx) data were analyzed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.